Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 29, 2012
Oct. 01, 2011
Cash flows from operating activities:    
Net income $ 30,704 $ 31,604
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,353 5,025
Gain on investment in HCT   (1,244)
(Gain) Loss on disposal of assets 84 (27)
Provision for deferred income taxes 4  
Allowance for doubtful accounts 44 16
Stock-based compensation expense 1,639 1,218
(Increase) decrease in, net of acquisition:    
Accounts receivable (2,309) (2,927)
Inventories (147) (823)
Income taxes receivable 120 866
Other current assets 86 (488)
Other assets (92) (88)
Increase (decrease) in, net of acquisition:    
Accounts payable 65 1,534
Accrued expenses and other liabilities 3,722 3,535
Income taxes payable 1,047  
Other noncurrent liabilities (219) (202)
Net cash provided by operating activities 40,101 37,999
Cash flows from investing activities:    
Proceeds from sale of joint venture   1,451
Acquisition of business, net of cash acquired   (1,776)
Capital expenditures (6,703) (6,778)
Proceeds from dispositions 56 30
Purchases of marketable securities (25,774) (13,516)
Proceeds from sale of marketable securities 6,821 6,497
Net cash used in investing activities (25,600) (14,092)
Cash flows from financing activities:    
Proceeds from exercise of stock options   61
Proceeds from stock issued 506 408
Dividends to shareholders (10,107) (7,284)
Net cash used in financing activities (9,601) (6,815)
Effect of exchange rate changes on cash and cash equivalents 762 (707)
Net increase in cash and cash equivalents 5,662 16,385
Cash and cash equivalents, beginning of period 45,080 33,206
Cash and cash equivalents, end of period 50,742 49,591
Cash Paid [Abstract]    
Income taxes 14,323 14,503
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities 4,407 2,412
Common stock issued for deferred director's compensation through other noncurrent liabilities $ 930